Digital Medicines Head, Pharma

Location: Basel, Switzerland
Job Type: Full-Time
Employer: Novartis
The Digital Medicines Head is responsible for leveraging world-class digital medicines capabilities to transform how we deliver value to our customers at scale. You will enrich and improve the patient journey and experience through digital interventions to accelerate access to treatment, reduce pain points, increase awareness of medicines and improve treatment adherence. You will expand healthcare solutions beyond the drug and solve future patient challenges by gaining real-time data and real-world evidence through digital solutions and technologies and enable future launch success by addressing key customer needs across the entire customer journey prior to, during and post launch.

We are looking for a self-aware, inspired and curious leader who empowers and supports others in an unbossed manner. This leader should have a strong focus on people development and help teams collaborate in a matrix organization.

Your responsibilities include, but are not limited to:

  • Deliver a clear and compelling vision and strategy for the digital patient journey vision that aligns and enriches the commercial portfolio and enables launch excellence and execution, taking the business with them
  • Inspire and empower the team in an unbossed leadership manner allowing people to be at their best to deliver on the digital vision and strategy
  • Ensure co-creation and tight collaboration with key stakeholders including Commercial, Medical and Access and execution in close partnership with the Regions and Countries
  • Create a clear plan to build innovative digital solutions that deliver desired outcomes and includes a multichannel approach
  • Create platform solutions that can join up Health Care Professionals / patients / health systems seamlessly, and can be leveraged across various brands or launches to deliver business impact
  • Build internal capabilities to enable re-thinking and/or enhancing of go-to-market strategies
  • Identify and collaborate with external partners to identify optimal digital solutions and solve digital challenges most applicable to the patient journey and commercial excellence
  • Ensure scalability and future deployment of digital solutions in key markets

Minimum requirements

What you'll bring to the role:
  • University degree in business and/or innovation technology (preferred)
  • 10+ years of Business experience (ideally in the health care industry), including 5+ years digital experience
  • Inspirational leadership with high level of self-awareness and curiosity with focus on empowering others, people development and collaboration in a matrix
  • Digital marketing experience with proven track record of success and knowledge of User/patients Experience (UX) and customer experience, and applicable customer-oriented digital healthcare solutions at scale
  • Prior experience creating and utilizing digital solutions to solve challenging and complex problems and to generate revenue
  • Previous experience managing digital platforms, technology and large-scale data
  • Innovative and entrepreneurial mindset with ability to turn opportunities into high value outcomes

Apply for this job

About Novartis

Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 105,000 people of more than 140 nationalities work at Novartis around the world.

Post your job offer now to start hiring the best digital health talent! For further information, please contact us.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...